• Profile
Close

Hor­monal con­tra­cept­ives and hair dyes in­crease breast can­cer risk

University of Helsinki Faculty of Medicine News Mar 22, 2017

Age is the most important risk factor of breast cancer but current study suggests that the use of hormonal intrauterine device increases the breast cancer risk significantly. In her recent doctoral dissertation, researcher Sanna Heikkinen from the University of Helsinki and Finnish Cancer Registry evaluates the contribution of the use of hormonal contraceptives and hair dyes to the spectrum of breast cancer risk factors.

The analysis included self–reported survey data from 8000 breast cancer patients and 20 000 controls from Finland.

According to the results, use of hormonal intrauterine device was associated with 52% increased risk of breast cancer in post–menopausal women, when compared to women who had used copper intrauterine device.

The use of other hormonal contraceptives was, by contrast, associated with 32% higher breast cancer risk among younger women under 50 when compared to women who did not use hormonal contraceptives.

There was also a 23% observed increase in the risk of breast cancer among women who dyed their hair compared to those who didn’t.

To confirm the roles of these factors, further research on the effects of hormonal contraceptives, most specifically hormonal intrauterine device, and hair dyes is needed with other populations and a prospective study design.

"The biggest risk factor in breast cancer is high age, and known lifestyle–related risk factors include late age at first birth, small number of children, high alcohol consumption, and sedentary lifestyle," Heikkinen stresses.

Many of these factors have become significantly more common in Western countries, including Finland, during the last decades.

In her research, Heikkinen also investigated the amount of opportunistic mammography, which was found to be very common. More than 60% of responders reported having had a mammography before the screening age of 50.

"Women should be more extensively informed of the harms of opportunistic mammography, such as accumulating radiation burden and the potential consequences of false positive or negative findings," Heikkinen says.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay